Adage Capital Partners Gp, L.L.C. Centessa Pharmaceuticals PLC Transaction History
Adage Capital Partners Gp, L.L.C.
- $51.6 Billion
- Q1 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 6,954,000 shares of CNTA stock, worth $94.4 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
6,954,000
Previous 5,119,027
35.85%
Holding current value
$94.4 Million
Previous $85.7 Million
16.63%
% of portfolio
0.19%
Previous 0.16%
Shares
8 transactions
Others Institutions Holding CNTA
# of Institutions
131Shares Held
120MCall Options Held
104KPut Options Held
294K-
Medicxi Ventures Management (Jersey) LTD20MShares$271 Million75.25% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$135 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$131 Million4.7% of portfolio
-
Janus Henderson Group PLC London, X05.92MShares$80.4 Million0.05% of portfolio
-
First Light Asset Management, LLC Edina, MN5.81MShares$78.8 Million9.51% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.28B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...